The latest health news
When is a pandemic “over?” Did biotech over-SPAC? And what can’t be CRISPR’d? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Heidi Tworek, …
Read More
Can CRISPR edit out a heart attack? What happens on #GutTok? And is health care recession-proof? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech …
Read More
Twenty-three years ago, the field of gene therapy was bursting with the promise of breakthrough treatments. Then it was almost instantly derailed by the death of an 18-year-old clinical trial …
Read More
On June 28, 2012, a joint press release went out from the U.S. Department of Energy and the Lawrence Berkeley National Laboratory announcing a new paper in Science from an …
Read More
Australia has become the second country in the world to explicitly authorize and regulate mitochondrial replacement therapies, offering hope to some families who want to have children but fear passing …
Read More
NEW YORK — Earlier this month, the U.S. Patent and Trademark Office ruled that CRISPR patents key to developing human therapies belong to the Broad Institute of MIT and Harvard, …
Read More
Is “test to treat” too good to be true? Does it really matter who gets credit for CRISPR? And what’s the offramp for Covid-19? We cover all that and more …
Read More
I am a biotech investor and entrepreneur. But more central to my worldview is that I am someone who lives with a rare genetic disease. This has sensitized me to …
Read More
Editor’s note: A livestream of the event is embedded below Last summer Intellia reported the first data showing that CRISPR could be used in the body to combat a disease …
Read More